Diabetes Drug ‘Significantly Reverses Memory Loss’ In Mice With Alzheimer’s

Diabetes Drug ‘Significantly Reverses Memory Loss’ In Mice With Alzheimer’s

Diabetes and Alzheimers are two seemingly unrelated diseases, until recently. Research conducted on a popular diabetes drug has spawned a stunning discovery. According to Brain Research, a drug commonly used to treat type 2 diabetes could bring significant relief to patients who suffer from Alzheimers disease. The study used mice with human genetic mutations in which the diabetes drug was administered during a maze test. Mice whom had taken the diabetes medication experienced much improved learning and memory capabilities. Type 2 diabetes creates a higher risk for Alzheimers and is suspected to progress Alzheimers. Therefore, this discovery shows promising outcomes for treating both diseases with one method. The use of a drug for type 2 diabetes for treating Alzheimers has powerful benefits, due to the triple receptor drug acting in various ways to protect the brain, memory and functioning from degeneration. The type 2 diabetes drug benefits individuals suffering from Alzheimers by slowing down the rate of nerve cell damage and loss, enhances brain growth as a direct defense against Alzheimers, reduces brain inflammation and a host of other benefits. This treatment has to be explored further to decide if using a type 2 diabetes drug shows real promise for people with Alzheimers and other forms of dementia.

Key Points:

  • 1Researchers in the United Kingdom have found that a drug used for diabetes may also offer relief to Alzheimer’s Disease patients.
  • 2Alzheimer’s Disease currently has no clear way to be treated; researchers are encouraged by this latest discovery that could give patients an option.
  • 3Most dementia patients have Alzheimer’s Disease, and the numbers of those afflicted with the disease are on the rise.


Although the benefits of these ‘triple agonist’ drugs have so far only been found in mice, other studies with existing diabetes drugs such as liraglutide have shown real promise for people with Alzheimer’s, so further development of this work is crucial.”
Follow us

HealthStatus

HealthStatus has been operating since 1998 providing the best interactive health tools on the Internet, millions of visitors have used our health risk assessment, body fat and calories burned calculators.The HealthStatus editorial team has continued that commitment to excellence by providing our visitors with easy to understand high quality health content for many years.
Follow us
Share

HealthStatus has been operating since 1998 providing the best interactive health tools on the Internet, millions of visitors have used our health risk assessment, body fat and calories burned calculators. The HealthStatus editorial team has continued that commitment to excellence by providing our visitors with easy to understand high quality health content for many years.

Leave a Reply

Your email address will not be published. Required fields are marked *